/

Empresas

Ni

No verificado

Niagen Bioscience, Inc

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaSaludWeb y redes sociales

32 Comunicados de prensa

Ver todos los comunicados de prensa

10/03/2026

Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen®

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

04/03/2026

Web y redes sociales

Telefonía

Mercado de valores

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

26/02/2026

Administración de Empresas

Salud

Fitness

Sanidad

Farmacéutica

Biotecnología

Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

25/02/2026

Industria

Salud

Ciencia

Farmacéutica

Biotecnología

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

06/02/2026

Biotecnología

Salud

Fitness

Farmacéutica

Web y redes sociales

Telefonía

Finanzas

Mercado de valores

Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

15/01/2026

Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.*

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

22/12/2025

Lujo

Venta al público/Minorista

Accesorios de moda

Sanidad

Salud

Cosmética

Ciencia

Mercado de valores

Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

13/11/2025

Multimedia

Cosmética

Comercio electrónico/E-commerce

Venta al público/Minorista

Lujo

Salud

Industria

Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

13/11/2025

Ciencia

Psiquiatría

VIH, SIDA y enfermedades autoinmunes

Medicina - Varios

Biotecnología

Farmacéutica

Salud

Industria

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

06/11/2025

Salud

Sanidad

Ciencia

Farmacéutica

Biotecnología

Finanzas

Niagen Bioscience Announces $10 Million Share Repurchase Program

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

Seguidores

0

Compatibilidad

0